{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:40:13Z","timestamp":1752212413642,"version":"3.41.2"},"reference-count":30,"publisher":"Jaypee Brothers Medical Publishing","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.59556\/japi.72.0564","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:22:26Z","timestamp":1752211346000},"page":"44-48","source":"Crossref","is-referenced-by-count":0,"title":["Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India"],"prefix":"10.59556","volume":"72","author":[{"given":"Prabhat","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhil Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranay Singh","family":"Chakotiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(1):","key":"key20250711052220_B1","first-page":"e21054.","article-title":"Study of profile of mucormycosis during the second wave of COVID-19 in a tertiary care hospital.","volume":"14","author":"Kamath","year":"2022;","journal-title":"Cureus"},{"key":"key20250711052220_B2","doi-asserted-by":"crossref","first-page":"100153.","DOI":"10.1016\/j.puhip.2021.100153","article-title":"Mucormycosis or black fungus is a new fright in India during COVID-19 pandemic: associated risk factors and actionable items.","volume":"2:","author":"Moona","year":"2021;","journal-title":"Public Health Pract (Oxf)"},{"issue":"(4):","key":"key20250711052220_B3","doi-asserted-by":"crossref","first-page":"102146.","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India.","volume":"15","author":"Singh","year":"2021;","journal-title":"Diabetes Metab Syndr"},{"key":"key20250711052220_B4","doi-asserted-by":"crossref","first-page":"150\u2013","DOI":"10.4103\/injms.injms_15_22","article-title":"An analysis of proposed etiological factors for sudden spike in mucormycosis infection during COVID-19 pandemic at a tertiary hospital of North India.","volume":"13:","author":"Singh","year":"2022;","journal-title":"Indian J Med Spec"},{"issue":"(4):","key":"key20250711052220_B5","doi-asserted-by":"crossref","first-page":"265.","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update.","volume":"6","author":"Skiada","year":"2020;","journal-title":"J Fungi"},{"key":"key20250711052220_B6","doi-asserted-by":"crossref","first-page":"26.","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis.","volume":"5:","author":"Prakash","year":"2019;","journal-title":"J Fungi"},{"issue":"(3):","key":"key20250711052220_B7","doi-asserted-by":"crossref","first-page":"556\u2013","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management.","volume":"18","author":"Spellberg","year":"2005;","journal-title":"Clin Microbiol Rev"},{"issue":"(3):","key":"key20250711052220_B8","doi-asserted-by":"crossref","first-page":"418\u2013","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis.","volume":"20","author":"Moorthy","year":"2021;","journal-title":"J Maxillofac Oral Surg"},{"issue":"(13):","key":"key20250711052220_B9","doi-asserted-by":"crossref","first-page":"3620.","DOI":"10.3390\/jcm11133620","article-title":"Current treatment options for COVID-19 associated mucormycosis: present status and future perspectives.","volume":"11","author":"Madhavan","year":"2022;","journal-title":"J Clin Med"},{"key":"key20250711052220_B10","doi-asserted-by":"crossref","first-page":"193\u2013","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.","volume":"47:","author":"Yang","year":"2010;","journal-title":"Acta Diabetol"},{"issue":"(9):","key":"key20250711052220_B11","first-page":"663\u2013","article-title":"Transient diabetes following chicken pox.","volume":"38","author":"Jali","year":"1990;","journal-title":"J Assoc Physicians India"},{"issue":"(Suppl 2):","key":"key20250711052220_B12","doi-asserted-by":"crossref","first-page":"S483\u2013","DOI":"10.1016\/j.mjafi.2021.04.009","article-title":"New-onset diabetes mellitus with COVID-19: coincidence or cause.","volume":"77","author":"Muthukrishnan","year":"2021;","journal-title":"Med J Armed Forces India"},{"key":"key20250711052220_B13","first-page":"e13163.","article-title":"A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19.","volume":"13:","author":"Waizel-Haiat","year":"2021;","journal-title":"Cureus"},{"issue":"(7)","key":"key20250711052220_B14","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.","volume":"26","author":"Patel","year":"2020;","journal-title":"Clin Microbiol Infect"},{"issue":"(12):","key":"key20250711052220_B15","first-page":"1859e67.","article-title":"Zygomycosis in europe: analysis of 230 cases accrued by the registry of the European confederation of medical mycology (ECMM) working group on zygomycosis between 2005 and 2007.","volume":"17","author":"Skiada","year":"2011;","journal-title":"Clin Microbiol Infect"},{"issue":"(4):","key":"key20250711052220_B16","doi-asserted-by":"crossref","first-page":"261\u2013","DOI":"10.1053\/jinf.2001.0831","article-title":"Ten years\u2019 experience in zygomycosis at a tertiary care centre in India.","volume":"42","author":"Chakrabarti","year":"2001;","journal-title":"J Infect"},{"issue":"(4):","key":"key20250711052220_B17","doi-asserted-by":"crossref","first-page":"102196.","DOI":"10.1016\/j.dsx.2021.102196","article-title":"Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India.","volume":"15","author":"Mishra","year":"2021;","journal-title":"Diabetes Metab Syndr"},{"issue":"(5):","key":"key20250711052220_B18","first-page":"634e53.","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases.","volume":"41","author":"Roden","year":"2005;","journal-title":"Clin Infect Dis"},{"issue":"(4):","key":"key20250711052220_B19","doi-asserted-by":"crossref","first-page":"640\u2013","DOI":"10.47203\/IJCH.2021.v33i04.017","article-title":"Mucormycosis during second wave of COVID-19 in India: exploratory analysis from tertiary care centre of Uttar Pradesh.","volume":"33","author":"Singh","year":"2021;","journal-title":"Indian J Comm Health"},{"key":"key20250711052220_B20","doi-asserted-by":"crossref","first-page":"346\u2013","DOI":"10.1128\/iai.46.2.346-353.1984","article-title":"Estrogens inhibit mycelium-to-yeast transformation in the fungus Paracoccidioides brasiliensis: implications for resistance of females to paracoccidioidomycosis.","volume":"46:","author":"Restrepo","year":"1984;","journal-title":"Infect Immun"},{"key":"key20250711052220_B21","doi-asserted-by":"crossref","first-page":"26\u2013","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.","volume":"25:","author":"Jeong","year":"2019;","journal-title":"Clin Microbiol Infect"},{"key":"key20250711052220_B22","doi-asserted-by":"crossref","first-page":"115\u2013","DOI":"10.1007\/s40121-020-00382-7","article-title":"Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections.","volume":"10:","author":"Cavassin","year":"2021;","journal-title":"Infect Dis Ther"},{"issue":"(1):","key":"key20250711052220_B23","doi-asserted-by":"crossref","first-page":"126\u2013","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis.","volume":"50","author":"Greenberg","year":"2006;","journal-title":"Antimicrob Agents Chemother"},{"key":"key20250711052220_B24","doi-asserted-by":"crossref","first-page":"101044.","DOI":"10.1016\/j.molmet.2020.101044","article-title":"Diabetes, infection risk and COVID-19.","volume":"39:","author":"Erener","year":"2020;","journal-title":"Mol Metab"},{"issue":"(3):","key":"key20250711052220_B25","doi-asserted-by":"crossref","first-page":"549\u2013","DOI":"10.1002\/rth2.12109","article-title":"The coagulation system in host defense.","volume":"2","author":"Antoniak","year":"2018;","journal-title":"Res Pract Thromb Haemost"},{"issue":"(1):","key":"key20250711052220_B26","doi-asserted-by":"crossref","first-page":"44\u2013","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus: a hypercoagulable state.","volume":"15","author":"Carr","year":"2001;","journal-title":"J Diabetes Complications"},{"issue":"(1):","key":"key20250711052220_B27","doi-asserted-by":"crossref","first-page":"34.","DOI":"10.1186\/s12933-017-0515-9","article-title":"Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.","volume":"16","author":"Kearney","year":"2017;","journal-title":"Cardiovasc Diabetol"},{"issue":"(1):","key":"key20250711052220_B28","doi-asserted-by":"crossref","first-page":"82\u2013","DOI":"10.1182\/blood-2007-11-121723","article-title":"Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.","volume":"112","author":"Stegenga","year":"2008;","journal-title":"Blood"},{"key":"key20250711052220_B29","doi-asserted-by":"crossref","first-page":"rjab010.","DOI":"10.1093\/jscr\/rjab010","article-title":"Complicated sinusitis with sphenopalatine artery thrombosis in a COVID-19 patient: a case report.","volume":"2021:","author":"Ahmed","year":"2021;","journal-title":"J Surg Case Rep"},{"key":"key20250711052220_B30","doi-asserted-by":"crossref","first-page":"101\u2013","DOI":"10.1016\/j.thromres.2020.06.029","article-title":"The hypercoagulable state in COVID-19: incidence, pathophysiology, and management.","volume":"194:","author":"Abou-Ismail","year":"2020;","journal-title":"Thromb Res"}],"container-title":["Journal of the Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T05:22:29Z","timestamp":1752211349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-72-6-44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.59556\/japi.72.0564"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0564","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}